Challenges in managing atypical glandular cells in cervical smears: Insights from real‐world data and clinicians' perspectives
Journal of Obstetrics and Gynaecology Research · 2025-03 · 51 (3)
DOI: 10.1111/jog.16269 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, online erschienen am 18.03.2025. Verfasst von Mika Mizuno und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Faculty of Medicine, Kagoshima University, Kagoshima, Japan. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Vaginal Smears, Adenocarcinoma, Practice Patterns, Physicians'. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
Objective
This study evaluates clinicopathological outcomes and clinicians' awareness regarding the management of atypical glandular cells (AGC).
Methods
We analyzed 98 AGC cases, excluding known endometrial cancer, from 238 initial cases, with a median age of 42 years (range 20–82). Cytological findings, including NOS and FN subcategories, diagnostic tests, treatments, and outcomes were evaluated. A survey on AGC awareness and practices was conducted among 134 obstetrician‐gynecologists.
Results
Of 98 cases (AGC‐FN: 19.8%, AGC‐NOS: 13.2%, unspecified: 67.3%), 44.9% initially showed no neoplasia; this dropped to 38.8% following up, identifying 11 additional AIS or cervical adenocarcinomas. Overall, 28.5% had AIS or more, 18% had CIN, and 13.3% had other malignancies, indicating some over/underdiagnosis. HPV testing in 79 cases showed a 48.1% positivity rate, including 14 type‐18 and 12 type‐16 cases. Among clinicians surveyed, 25% were aware of AGC subcategories, and only 11.9% were well‐versed. Approximately 65% associated AGC with malignancy or precancerous lesions, and 52.6% used multiple diagnostic methods simultaneously. Even in the absence of neoplasia, 80% continued cytological examinations every 3–4 months.
Conclusion
This study underscores the challenges in AGC management, highlighting the importance of follow‐up and collaboration between clinicians and cytopathologists to detect significant lesions. It also emphasizes the need for providing learning opportunities for clinicians to address over/undertreatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Faculty of Medicine, Kagoshima University, Kagoshima, Japan.
ORCID-Profile: Mika Mizuno, Shinichi Togami, Hiroaki Kobayashi
Zitieren
APA
Mizuno, M., Nakazono, M., Furuzono, N., Kobayashi, Y., Fukuda, M., Togami, S., & Kobayashi, H. (2025). Challenges in managing atypical glandular cells in cervical smears: Insights from real‐world data and clinicians' perspectives. Journal of Obstetrics and Gynaecology Research, 51(3). https://doi.org/10.1111/jog.16269
Vancouver
Mizuno M, Nakazono M, Furuzono N, Kobayashi Y, Fukuda M, Togami S, et al. Challenges in managing atypical glandular cells in cervical smears: Insights from real‐world data and clinicians' perspectives. Journal of Obstetrics and Gynaecology Research. 2025;51(3). doi:10.1111/jog.16269
BibTeX
@article{Mizuno2025,
author = {Mizuno, Mika and Nakazono, Mai and Furuzono, Nozomi and Kobayashi, Yusuke and Fukuda, Mika and Togami, Shinichi and Kobayashi, Hiroaki},
title = {Challenges in managing atypical glandular cells in cervical smears: Insights from real‐world data and clinicians' perspectives},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2025},
volume = {51},
number = {3},
doi = {10.1111/jog.16269}
}
EUVIMED